These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3945435)

  • 1. Treatment of hyperprolactinemic amenorrhea with Metergoline.
    Bohnet HG; Kato K; Wolf AS
    Obstet Gynecol; 1986 Feb; 67(2):249-52. PubMed ID: 3945435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metergoline in the management of hyperprolactinemic amenorrhea and anovulation.
    Falsetti L; Voltolini AM; Crosignani PG; Lotti G; Travaglini P; Faglia G; Cianci A; Palumbo G; Praga C; Pontiroli AE
    Gynecol Obstet Invest; 1982; 13(2):108-16. PubMed ID: 7035305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of cyclic ovarian function by metergoline treatment in a patient with a prolactin-secreting pituitary microadenoma.
    Ferrari C; Caldara R; Telloli P; Rampini P; Bertazzoni A
    Fertil Steril; 1978 Aug; 30(2):237-9. PubMed ID: 680200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metergoline and bromocriptine in the management of tumoral and idiopathic hyperprolactinemia.
    Falsetti L; Roggia A; Loda G; Turla R; Scagliola T; Schimberni M; Pontiroli AE
    Horm Metab Res; 1983 Aug; 15(8):380-4. PubMed ID: 6618428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature.
    Farrari C; Telloli P; Rampini P; Caldara R
    Gynecol Obstet Invest; 1980; 11(6):317-26. PubMed ID: 6785158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of the prolactin response to sulpiride by metergoline administration in hyperprolactinemic patients.
    Ferrari C; Travaglini P; Caldara R; Moriondo P; Mattei A; Crosignani PG; Faglia G
    Neuroendocrinology; 1979; 29(5):338-45. PubMed ID: 503288
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum prolactin and ovarian function after discontinuation of drug treatment for hyperprolactinaemia: a study with bromocriptine and metergoline.
    Mattei AM; Ferrari C; Ragni G; Benco R; Picciotti MC; Rampini P; Caldara R; Crosignani PG
    Br J Obstet Gynaecol; 1984 Mar; 91(3):244-50. PubMed ID: 6704349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metergoline as an alternative to bromocriptine in amenorrhoea.
    Hicks BH; Finer N; Herbert LC
    Acta Endocrinol (Copenh); 1984 Dec; 107(4):439-44. PubMed ID: 6440388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the ergoline derivative, CU 32-085, on prolactin secretion in hyperprolactinemic women.
    Hesla JS; Rodman EF; Molitch ME; Goodman LA; Chang RJ
    Fertil Steril; 1987 Oct; 48(4):555-9. PubMed ID: 3653414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experiences with the prolactin-inhibiting serotonin antagonist metergoline].
    Schneider WH; Huber H; Spona J
    Wien Klin Wochenschr; 1983 Jun; 95(13):452-5. PubMed ID: 6636776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methergoline therapy of hyperprolactinemic amenorrhea. Observations on 22 cases].
    Rossetti MG; Belforte L; Bruno M; Lanza MG; Peris C; Vaudano G; Campagnoli C
    Minerva Ginecol; 1981 Jun; 33(6):586-9. PubMed ID: 7279283
    [No Abstract]   [Full Text] [Related]  

  • 12. Metergoline treatment of hyperprolactinemic states.
    Crosignani PG; Ferrari C; Mattei A; Fadini R; Meschia M; Caldara R; Rampini P; Telloli P; Reschini E
    Fertil Steril; 1979 Sep; 32(3):280-5. PubMed ID: 488408
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation and treatment of hyperprolactinaemia in women of childbearing age.
    Marek J; Zivný J; Srámková J; Kucera E; Kobilková J
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():110-7. PubMed ID: 6242681
    [No Abstract]   [Full Text] [Related]  

  • 14. [Metergoline in hyperprolactinemic breast cancer: a phase II study].
    Holtkamp W; Nagel GA
    Onkologie; 1986 Oct; 9(5):245-8. PubMed ID: 3101016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy following metergoline treatment in a patient with hyperprolactinaemia.
    Crosignani PG; Reschini E; Peracchi M; D'Alberton A; Lombroso GC
    Br J Obstet Gynaecol; 1977 May; 84(5):386-8. PubMed ID: 889732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hyperprolactinemic states with different drugs: a study with bromocriptine, metergoline, and lisuride.
    Crosignani PG; Ferrari C; Liuzzi A; Benco R; Mattei A; Rampini P; Dellabonzana D; Scarduelli C; Spelta B
    Fertil Steril; 1982 Jan; 37(1):61-7. PubMed ID: 7199483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical results in the treatment with metergoline in 80 hyperprolactinemic patients].
    Falsetti L; Scagliola P; Turla R; Voltolini AM
    Minerva Med; 1981 Sep; 72(35):2351-4. PubMed ID: 7279256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of lysenyl-forte and methergoline in the therapy of hyperprolactinemic hypogonadism].
    Mel'nichenko GA; Dedov II; Gitel' EP; Ilovaĭskaia IA
    Probl Endokrinol (Mosk); 1991; 37(2):20-2. PubMed ID: 1857694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic evaluation of prolactin secretion in patients with oligospermia: effects of treatment with metergoline.
    Masala A; Delitala G; Alagna S; Devilla L; Rovasio PP; Lotti G
    Fertil Steril; 1979 Jan; 31(1):63-7. PubMed ID: 105938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and tolerability of long term treatment with cabergoline, a new long-lasting ergoline derivative, in hyperprolactinemic patients.
    Ciccarelli E; Giusti M; Miola C; Potenzoni F; Sghedoni D; Camanni F; Giordano G
    J Clin Endocrinol Metab; 1989 Oct; 69(4):725-8. PubMed ID: 2570790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.